© 2020 MJH Life Sciences and OncLive. All rights reserved.
November 27, 2019
Jyoti D. Patel, MD, discusses the results of the CheckMate-227 trial, which looked at an immunotherapy combination versus chemotherapy in patients with advanced non–small cell lung cancer.
November 22, 2019
Jyoti D. Patel, MD, discusses immunotherapy combinations for patients with advanced nonsquamous non–small cell lung cancer.
October 29, 2019
Jyoti D. Patel, MD, discusses current immunotherapy options in stage IV non–small cell lung cancer.
February 17, 2018
Jyoti D. Patel, MD, professor of medicine, director of thoracic oncology, the University of Chicago Medicine, discusses the FDA approval of durvalumab (Imfinzi) in patients with non